CV Therapeutics (CVTX) Reports Q2 Loss of $0.07

July 31, 2008 4:14 PM EDT Send to a Friend

CV Therapeutics (Nasdaq: CVTX) reports a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

CV Therapeutics (CVTX) Reports Q2 Loss of $0.07

Member Login

Free News Feed